Hundreds of lawsuits allege that insulin manufacturers and pharmacy benefit managers colluded to raise prices. The ...

All three companies have had a tough time of it recently in the stock market. But in all three cases, our analysts think that ...

Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

In this week’s edition of InnovationRx, we look at the impact of Medicaid cuts, a $400 million obesity bet, a study of bias ...

Girls Next Door alum Kendra Wilkinson shared that she recently tried using a weight loss drug but quickly changed her mind, citing “too many horror stories around me.” ...

This Consequence is the sound of pent-up aggression, a creative release after Killswitch were stopped in their tracks.

Originally marketed for treating Type 2 diabetes, Ozempic—perhaps the most ... A rep for the pharmaceutical company Novo Nordisk, which makes Ozempic, previously told E! News in a statement ...

That was just a year after Ozempic, Novo Nordisk’s diabetes drug ... Using Ricks’ north star of speed, and nudged by increasing competition in the field, O’Keeffe and her team took a ...

GLP-1 antidiabetic drugs, which reduce body mass by 25%, impact the processed food or alcohol industry and force fashion and insurance to transform. The unwanted side effect in medicine is any ...